Itzhak Kurek

Company: Cannformatics

Job title: Chief Executive Officer & Co-Founder

Seminars:

A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder 12:00 pm

Examine how successful autism spectrum disorder (ASD) treatment is challenging due to subjective evaluation of changes in social interaction, language and communication ability, and repetitive behaviors, observed by clinician and family members of the individual with ASD Study metabolic biomarkers and how they are an attractive method to quantify and personalize medical cannabis (MC) treatment…Read more

day: Day 2 Track B - Morning